Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Treatment simplification strategies

Two-antiretroviral maintenance failure - raltegravir regimens seem most vulnerable

Editor's pick
NATAP
29 March 2019
Access to healthcare

EACS Standard of Care meeting report – Tackling HIV and co-infections in Europe: towards common standards

News
29 March 2019
Contraception

Efavirenz and rifampicin together reduce levels of injectable contraception

Editor's pick
HIV i-Base
29 March 2019
Contraception

Double-dose levonorgestrel implant does not overcome interaction with efavirenz

Editor's pick
HIV i-Base
29 March 2019
Harm reduction

Opioid overdose deaths are rising among people with HIV in the United States

News
28 March 2019
Side effects

HIV Drugs With Fewer Side Effects Need More FDA Support

Editor's pick
HivPlusMag.com
27 March 2019
Pharmaceutical industry

Non-adherence to HIV treatment for cost-saving reasons reported by 8% in American study

News
27 March 2019
New & experimental HIV treatments

Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%

Editor's pick
Motley Fool
24 March 2019
Weight gain & lipodystrophy

The impact of older antiretrovirals on fat redistribution and cardiovascular risk factors may be irreversible

News
21 March 2019
New & experimental HIV treatments

Trogarzo’s Effects on Hard-to-Treat HIV Are Stable Over Two Years

Editor's pick
Poz
20 March 2019
People with limited treatment options

South Africa: Shortage of drug puts thousands of Aids patients at risk

Editor's pick
Independent Online
15 March 2019
Viral load

More than 1 year to HIV control raises failure risk almost 10-fold

Editor's pick
NATAP
15 March 2019
Improving HIV care

Up to 95% virologic response rate with rapid ART in safety-net clinic

Editor's pick
NATAP
14 March 2019
Side effects

Inactive Ingredients in Medications Cause Trouble for Some

Editor's pick
Medscape (requires free registration)
14 March 2019
Drug-resistant TB

TB CAB statement on safety of using bedaquiline and delamanid together

Editor's pick
TB Online
14 March 2019
Changing treatment

Dolutegravir-based second-line ART achieves excellent virological outcomes even in the presence of resistance to recycled NRTIs

News
13 March 2019
Side effects

Large French study examines neuropsychiatric side effects with integrase inhibitors

Editor's pick
CATIE
12 March 2019
People with limited treatment options

Can high-dose dolutegravir be a rescue therapy?

Editor's pick
CATIE
12 March 2019
Treatment outcomes & life expectancy

Wider ART Rollout Tied to Declines in HIV Mortality in Kenya

Editor's pick
MedPage Today
12 March 2019
Treatment simplification strategies

Laura Waters, MD, FRCP: Can Two Drugs Tango?

Editor's pick
Contagion Live
12 March 2019
Drug interactions & pharmacokinetics

Double doses of darunavir given with rifampicin lead to high rates of hepatoxicity

Editor's pick
HIV i-Base
12 March 2019
TB transmission & prevention

Co-administration of dolutegravir-based treatment and short course of rifapentine/isoniazid (3HP) well tolerated in people living with HIV

News
12 March 2019
Improving HIV care

EACS takes steps towards a common, auditable European standard of care

News
11 March 2019
New & experimental HIV treatments

HIV capsid inhibitor may offer long-term viral suppression

News
11 March 2019